EZHIP and neoplasm: Around 95% of PFA tumours aberrantly express the EZHIP protein, which mimics the H3K27M oncohistone and potently inhibits PRC2 [94], while H3K27M mutations are found in the remaining ~ 5% in a mutually exclusive manner [97].